Chemical Structure (Cerebyx 01)
Cerebyx Injection, Solution
Product Images NDC 0069-5474
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cerebyx (NDC 0069-5474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Cerebyx 02)
Logo (Cerebyx 03)
Principal Display Panel (10 mL Vial Label)
This is a description of a medication labeled as " (fosphenytoin sodium) Injection" with a concentration of 500 mg PE/10 mL. The information suggests that this medication is for intramuscular or intravenous use and each single dose vial contains 10mL of the medication. The recommended dosage and usage is included in the package insert. This medication needs to be stored under refrigeration at specified conditions. The manufacturer of the medication is "Div.of Pizernc NY, N 10017 (50mg PE/mL)".*
Principal Display Panel (10 mL Vial Package)
This is a description of Cerebyxe, which is an injection used for Intramuscular or Intravenous use. It contains phenytoin sodium equivalents and comes in single-dose vials of 10 mL each. Each vial has 500 mg PE/10 mL (50 mg PE/mL), and the package contains 10 vials. The product should be stored under refrigeration and should not be stored at room temperature for more than 48 hours. The dosage and usage information can be found in the package insert. Note: Administration of this product differs from parenteral phenytoin.*
Principal Display Panel (2 mL Vial Label)
Cerebyxe is an injection used for intramuscular or intravenous use. Each vial of Cerebyxe contains fosphenytoin sodium 150mg equivalent to 100mg phenytoin sodium. This medication is distributed by Pfizer Labs division in New York and its NDC number is 0069-5471-01. Cerebyxe is available in a 2mL single-dose vial with a concentration of 100mg PE/2mL (50mg PE/mL). For dosage and use instructions, please refer to the package insert.*
Principal Display Panel (2 mL Vial Carton)
Cerebyx is an injection solution of fosphenytoin sodium indicated for intravenous or intramuscular use. The single-dose vial contains 100mg PE/2 mL. It should be stored under refrigeration and should not be kept at room temperature for more than 48 hours. This product is for single-use only. Dose of Cerebyx is expressed as phenytoin sodium equivalents. Please refer to the package insert for complete information on dosage and administration, including administration from parenteral phenytoin. Vials with particulate matter should not be used.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
